Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients--United States, 2005

Area of Science:

• Infectious Diseases
• Public Health
• Microbiology

Background:

• Staphylococcus aureus is a major cause of invasive infections in the U.S.
• Antimicrobial resistance in S. aureus is a growing concern, particularly in healthcare settings.
• Dialysis patients are particularly susceptible to infections by antimicrobial-resistant pathogens like MRSA.

Purpose of the Study:

• To determine the incidence of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections among dialysis patients in the United States during 2005.
• To compare MRSA infection rates in dialysis patients to the general population.
• To highlight the need for enhanced surveillance and infection control for this vulnerable group.

Main Methods:

• Analysis of surveillance data from the Active Bacterial Core surveillance (ABCs) system for the year 2005.
• Estimation of invasive MRSA infection incidence per 1,000 population among dialysis patients.
• Comparison of estimated incidence rates with those reported for the general population.

Main Results:

• The estimated incidence of invasive MRSA infection among dialysis patients in 2005 was 45.2 cases per 1,000 population.
• This rate is substantially higher than invasive MRSA rates in the general population, which ranged from 0.2 to 0.4 cases per 1,000 population.
• Dialysis patients represent a high-risk group for invasive MRSA infections.

Conclusions:

• Dialysis patients are at significantly elevated risk for invasive MRSA infections compared to the general population.
• Findings underscore the critical need for ongoing surveillance of MRSA infections in dialysis patients.
• Continued implementation and refinement of infection-control strategies are essential to reduce infection rates and combat antimicrobial resistance in this population.